Exact Mass: 473.2346
Exact Mass Matches: 473.2346
Found 500 metabolites which its exact mass value is equals to given mass value 473.2346
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
CD 1790
CD 1790 is a metabolite of linagliptin. Linagliptin (BI-1356, trade names Tradjenta and Trajenta) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes. Linagliptin (once-daily) was approved by the US FDA on 2 May 2011 for treatment of type II diabetes. It is being marketed by Boehringer Ingelheim and Lilly. (Wikipedia)
(2R)-5-(Diaminomethylideneamino)-2-[[2,2-di(phenyl)acetyl]amino]-N-[(4-hydroxyphenyl)methyl]pentanamide
Charantin
Charantin, also known as naftidrofuryl or nafronyl, is a member of the class of compounds known as naphthalenes. Naphthalenes are compounds containing a naphthalene moiety, which consists of two fused benzene rings. Charantin is practically insoluble (in water) and a very strong basic compound (based on its pKa). Charantin can be found in bitter gourd, which makes charantin a potential biomarker for the consumption of this food product. Charantin is actually a 1:1 mixture of two steroidal saponins, beta-sitosteryl glucoside (C 35H 60O 6) and 5,25-stigmasteryl glucoside (C 35H 58O 6). It is a whitish crystalline substance, neutral and tasteless, melting at 266‚Äì268 ¬∞C. It is sparingly soluble in water or other highly polar solvents, as well as in apolar solvents like hexane, but is soluble in ether, ethanol and methanol, and can be efficiently extracted from the plant by pressurized ethanol or acetone at 100 ¬∞C . Charantin, also known as naftidrofuryl or nafronyl, is a member of the class of compounds known as naphthalenes. Naphthalenes are compounds containing a naphthalene moiety, which consists of two fused benzene rings. Charantin is practically insoluble (in water) and a very strong basic compound (based on its pKa). Charantin can be found in bitter gourd, which makes charantin a potential biomarker for the consumption of this food product. Charantin is actually a 1:1 mixture of two steroidal saponins, β-sitosteryl glucoside (C 35H 60O 6) and 5,25-stigmasteryl glucoside (C 35H 58O 6). It is a whitish crystalline substance, neutral and tasteless, melting at 266–268 °C. It is sparingly soluble in water or other highly polar solvents, as well as in apolar solvents like hexane, but is soluble in ether, ethanol and methanol, and can be efficiently extracted from the plant by pressurized ethanol or acetone at 100 °C . Naftidrofuryl oxalate (Nafronyl oxalate salt) is a drug used in the management of peripheral and cerebral vascular disorders as a vasodilator, enhance cellular oxidative capacity, and may also be a 5-HT2 receptor antagonist.
16,17-didehydro-8-desmethoxy-isomigrastatin|16,17-didehydro-8-desmethylisomigrastatin
macropodumine K|rel-(3R,6R,10aS,11S,12aS)-5-(acetyloxy)-5a-[(acetyloxy)methyl]-12b-hydroxy-2,3,3a,5,5a,6,7,8,9,10,10a,11,12,12b-tetradecahydro-3-methyl-4H-1,6-methanocyclopenta[1,8]azuleno[4,3a-g]indole-11-carboxylic acid
Asn Val Ile Glu
Val Gln Ile Asp
Gln Val Ile Asp
Alverine citrate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent Alverine citrate is a 5-HT1A receptor antagonist, with an IC50 of 101 nM.
Ala Met Pro Arg
Ala Met Arg Pro
Ala Asn Asn Arg
Ala Asn Arg Asn
Ala Pro Met Arg
Ala Pro Arg Met
Ala Pro Thr Trp
Ala Pro Trp Thr
Ala Gln Gln Gln
Ala Arg Met Pro
Ala Arg Asn Asn
Ala Arg Pro Met
Ala Thr Pro Trp
Ala Thr Trp Pro
Ala Trp Pro Thr
Ala Trp Thr Pro
Cys Pro Arg Val
Cys Pro Val Arg
Cys Arg Pro Val
Cys Arg Val Pro
Cys Val Pro Arg
Cys Val Arg Pro
Asp Ile Ile Asn
Asp Ile Leu Asn
Asp Ile Asn Ile
Asp Ile Asn Leu
Asp Ile Gln Val
Asp Ile Val Gln
Asp Leu Ile Asn
Asp Leu Leu Asn
Asp Leu Asn Ile
Asp Leu Asn Leu
Asp Leu Gln Val
Asp Leu Val Gln
Asp Asn Ile Ile
Asp Asn Ile Leu
Asp Asn Leu Ile
Asp Asn Leu Leu
Asp Pro Arg Ser
Asp Pro Ser Arg
Asp Gln Ile Val
Asp Gln Leu Val
Asp Gln Val Ile
Asp Gln Val Leu
Asp Arg Pro Ser
Asp Arg Ser Pro
Asp Ser Pro Arg
Asp Ser Arg Pro
Asp Val Ile Gln
Asp Val Leu Gln
Asp Val Gln Ile
Asp Val Gln Leu
Glu Ile Asn Val
Glu Ile Val Asn
Glu Lys Pro Thr
Glu Lys Thr Pro
Glu Leu Asn Val
Glu Leu Val Asn
Glu Asn Ile Val
Glu Asn Leu Val
Glu Asn Val Ile
Glu Asn Val Leu
Glu Pro Lys Thr
Glu Pro Thr Lys
Glu Gln Val Val
Glu Thr Lys Pro
Glu Thr Pro Lys
Glu Val Ile Asn
Glu Val Leu Asn
Glu Val Asn Ile
Glu Val Asn Leu
Glu Val Gln Val
Glu Val Val Gln
Phe Asn Pro Pro
Phe Pro Asn Pro
Phe Pro Pro Asn
Gly Asn Gln Arg
Gly Asn Arg Gln
Gly Gln Asn Arg
Gly Gln Arg Asn
Gly Arg Asn Gln
Gly Arg Gln Asn
Ile Asp Ile Asn
Ile Asp Leu Asn
Ile Asp Asn Ile
Ile Asp Asn Leu
Ile Asp Gln Val
Ile Asp Val Gln
Ile Glu Asn Val
Ile Glu Val Asn
Ile Ile Asp Asn
Ile Ile Asn Asp
Ile Leu Asp Asn
Ile Leu Asn Asp
Ile Met Asn Pro
Ile Met Pro Asn
Ile Asn Asp Ile
Ile Asn Asp Leu
Ile Asn Glu Val
Ile Asn Ile Asp
Ile Asn Leu Asp
Ile Asn Met Pro
Ile Asn Asn Asn
Ile Asn Pro Met
Ile Asn Val Glu
Ile Pro Met Asn
Ile Pro Asn Met
Ile Gln Asp Val
Ile Gln Val Asp
Ile Val Asp Gln
Ile Val Glu Asn
Ile Val Asn Glu
Ile Val Gln Asp
Lys Glu Pro Thr
Lys Glu Thr Pro
Lys Pro Glu Thr
Lys Pro Thr Glu
Lys Thr Glu Pro
Lys Thr Pro Glu
Leu Asp Ile Asn
Leu Asp Leu Asn
Leu Asp Asn Ile
Leu Asp Asn Leu
Leu Asp Gln Val
Leu Asp Val Gln
Leu Glu Asn Val
Leu Glu Val Asn
Leu Ile Asp Asn
Leu Ile Asn Asp
Leu Leu Asp Asn
Leu Leu Asn Asp
Leu Met Asn Pro
Leu Met Pro Asn
Leu Asn Asp Ile
Leu Asn Asp Leu
Leu Asn Glu Val
Leu Asn Ile Asp
Leu Asn Leu Asp
Leu Asn Met Pro
Leu Asn Asn Asn
Leu Asn Pro Met
Leu Asn Val Glu
Leu Pro Met Asn
Leu Pro Asn Met
Leu Gln Asp Val
Leu Gln Val Asp
Leu Val Asp Gln
Leu Val Glu Asn
Leu Val Asn Glu
Leu Val Gln Asp
Met Ala Pro Arg
Met Ala Arg Pro
Met Ile Asn Pro
Met Ile Pro Asn
Met Leu Asn Pro
Met Leu Pro Asn
Met Asn Ile Pro
Met Asn Leu Pro
Met Asn Pro Ile
Met Asn Pro Leu
Met Pro Ala Arg
Met Pro Ile Asn
Met Pro Leu Asn
Met Pro Asn Ile
Met Pro Asn Leu
Met Pro Gln Val
Met Pro Arg Ala
Met Pro Val Gln
Met Gln Pro Val
Met Gln Val Pro
Met Arg Ala Pro
Met Arg Pro Ala
Met Val Pro Gln
Met Val Gln Pro
Asn Ala Asn Arg
Asn Ala Arg Asn
Asn Asp Ile Ile
Asn Asp Ile Leu
Asn Asp Leu Ile
Asn Asp Leu Leu
Asn Glu Ile Val
Asn Glu Leu Val
Asn Glu Val Ile
Asn Glu Val Leu
Asn Phe Pro Pro
Asn Gly Gln Arg
Asn Gly Arg Gln
Asn Ile Asp Ile
Asn Ile Asp Leu
Asn Ile Glu Val
Asn Ile Ile Asp
Asn Ile Leu Asp
Asn Ile Met Pro
Asn Ile Asn Asn
Asn Ile Pro Met
Asn Ile Val Glu
Asn Leu Asp Ile
Asn Leu Asp Leu
Asn Leu Glu Val
Asn Leu Ile Asp
Asn Leu Leu Asp
Asn Leu Met Pro
Asn Leu Asn Asn
Asn Leu Pro Met
Asn Leu Val Glu
Asn Met Ile Pro
Asn Met Leu Pro
Asn Met Pro Ile
Asn Met Pro Leu
Asn Asn Ala Arg
Asn Asn Ile Asn
Asn Asn Leu Asn
Asn Asn Asn Ile
Asn Asn Asn Leu
Asn Asn Gln Val
Asn Asn Arg Ala
Asn Asn Val Gln
Asn Pro Phe Pro
Asn Pro Ile Met
Asn Pro Leu Met
Asn Pro Met Ile
Asn Pro Met Leu
Asn Pro Pro Phe
Asn Gln Gly Arg
Asn Gln Asn Val
Asn Gln Arg Gly
Asn Gln Val Asn
Asn Arg Ala Asn
Asn Arg Gly Gln
Asn Arg Asn Ala
Asn Arg Gln Gly
Asn Val Glu Ile
Asn Val Glu Leu
Asn Val Leu Glu
Asn Val Asn Gln
Asn Val Gln Asn
Pro Ala Met Arg
Pro Ala Arg Met
Pro Ala Thr Trp
Pro Ala Trp Thr
Pro Cys Arg Val
Pro Cys Val Arg
Pro Asp Arg Ser
Pro Asp Ser Arg
Pro Glu Lys Thr
Pro Glu Thr Lys
Pro Phe Asn Pro
Pro Phe Pro Asn
Pro Ile Met Asn
Pro Ile Asn Met
Pro Lys Glu Thr
Pro Lys Thr Glu
Pro Leu Met Asn
Pro Leu Asn Met
Pro Met Ala Arg
Pro Met Ile Asn
Pro Met Leu Asn
Pro Met Asn Ile
Pro Met Asn Leu
Pro Met Gln Val
Pro Met Arg Ala
Pro Met Val Gln
Pro Asn Phe Pro
Pro Asn Ile Met
Pro Asn Leu Met
Pro Asn Met Ile
Pro Asn Met Leu
Pro Asn Pro Phe
Pro Pro Phe Asn
Pro Pro Asn Phe
Pro Gln Met Val
Pro Gln Val Met
Pro Arg Ala Met
Pro Arg Cys Val
Pro Arg Asp Ser
Pro Arg Met Ala
Pro Arg Ser Asp
Pro Arg Val Cys
Pro Ser Asp Arg
Pro Ser Arg Asp
Pro Thr Ala Trp
Pro Thr Glu Lys
Pro Thr Lys Glu
Pro Thr Trp Ala
Pro Val Cys Arg
Pro Val Met Gln
Pro Val Gln Met
Pro Val Arg Cys
Pro Trp Ala Thr
Pro Trp Thr Ala
Gln Ala Gln Gln
Gln Asp Ile Val
Gln Asp Leu Val
Gln Asp Val Ile
Gln Asp Val Leu
Gln Glu Val Val
Gln Gly Asn Arg
Gln Gly Arg Asn
Gln Ile Asp Val
Gln Ile Val Asp
Gln Leu Asp Val
Gln Leu Val Asp
Gln Met Pro Val
Gln Met Val Pro
Gln Asn Gly Arg
Gln Asn Asn Val
Gln Asn Arg Gly
Gln Asn Val Asn
Gln Pro Met Val
Gln Pro Val Met
Gln Gln Ala Gln
Gln Gln Gln Ala
Gln Arg Gly Asn
Gln Arg Asn Gly
Gln Val Asp Ile
Gln Val Asp Leu
Gln Val Glu Val
Gln Val Leu Asp
Gln Val Met Pro
Gln Val Asn Asn
Gln Val Pro Met
Gln Val Val Glu
Arg Ala Met Pro
Arg Ala Asn Asn
Arg Ala Pro Met
Arg Cys Pro Val
Arg Cys Val Pro
Arg Asp Pro Ser
Arg Asp Ser Pro
Arg Gly Asn Gln
Arg Gly Gln Asn
Arg Met Ala Pro
Arg Met Pro Ala
Arg Asn Ala Asn
Arg Asn Gly Gln
Arg Asn Asn Ala
Arg Asn Gln Gly
Arg Pro Ala Met
Arg Pro Cys Val
Arg Pro Asp Ser
Arg Pro Met Ala
Arg Pro Ser Asp
Arg Pro Val Cys
Arg Gln Gly Asn
Arg Gln Asn Gly
Arg Ser Asp Pro
Arg Ser Pro Asp
Arg Val Cys Pro
Arg Val Pro Cys
Ser Asp Pro Arg
Ser Asp Arg Pro
Ser Pro Asp Arg
Ser Pro Arg Asp
Ser Arg Asp Pro
Ser Arg Pro Asp
Thr Ala Pro Trp
Thr Ala Trp Pro
Thr Glu Lys Pro
Thr Glu Pro Lys
Thr Lys Glu Pro
Thr Lys Pro Glu
Thr Pro Ala Trp
Thr Pro Glu Lys
Thr Pro Lys Glu
Thr Pro Trp Ala
Thr Trp Ala Pro
Thr Trp Pro Ala
Val Cys Pro Arg
Val Cys Arg Pro
Val Asp Ile Gln
Val Asp Leu Gln
Val Asp Gln Ile
Val Asp Gln Leu
Val Glu Ile Asn
Val Glu Leu Asn
Val Glu Asn Ile
Val Glu Asn Leu
Val Glu Gln Val
Val Glu Val Gln
Val Ile Asp Gln
Val Ile Glu Asn
Val Ile Asn Glu
Val Ile Gln Asp
Val Leu Asp Gln
Val Leu Glu Asn
Val Leu Asn Glu
Val Leu Gln Asp
Val Met Pro Gln
Val Met Gln Pro
Val Asn Glu Ile
Val Asn Glu Leu
Val Asn Ile Glu
Val Asn Leu Glu
Val Asn Asn Gln
Val Asn Gln Asn
Val Pro Cys Arg
Val Pro Met Gln
Val Pro Gln Met
Val Pro Arg Cys
Val Gln Asp Ile
Val Gln Asp Leu
Val Gln Glu Val
Val Gln Leu Asp
Val Gln Met Pro
Val Gln Asn Asn
Val Gln Pro Met
Val Gln Val Glu
Val Arg Cys Pro
Val Arg Pro Cys
Val Val Glu Gln
Val Val Gln Glu
Trp Ala Pro Thr
Trp Ala Thr Pro
Trp Pro Ala Thr
Trp Pro Thr Ala
Trp Thr Ala Pro
Trp Thr Pro Ala
NBD-FTY720 phenoxy
Benzeneacetamide, 4,4-[[(1-methylethyl)imino]bis[(2-hydroxy-3,1-propanediyl)oxy]]bis
[1-[(2-methylpropan-2-yl)oxycarbonyl]-6-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-1-carbonyl]indol-2-yl]boronic acid
[1-[(2-methylpropan-2-yl)oxycarbonyl]-5-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-1-carbonyl]indol-2-yl]boronic acid
4-[5-(2-chlorophenyl)-4-[4-(dimethylamino)phenyl]-oxazol-2-yl]-N,N-dipropyl-aniline
4-cyano[1,1-biphenyl]-4-yl 4-heptyl[1,1-biphenyl]-4-carboxylate
Simenepag isopropyl
C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
2-(2,2-Diphenylacetamido)-5-guanidino-N-(4-hydroxybenzyl)pentanamide
(2E,10R)-10-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}undec-2-enoic acid
(2E)-11-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}undec-2-enoic acid
2-imino-10-methyl-N-[2-(4-morpholinyl)ethyl]-5-oxo-1-(3-pyridinylmethyl)-3-dipyrido[3,4-c:1,2-f]pyrimidinecarboxamide
Benzyl N-({(2s,3s)-3-[(Propylamino)carbonyl]oxiran-2-Yl}carbonyl)-L-Isoleucyl-L-Prolinate
Nafronyl oxalate
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Naftidrofuryl oxalate (Nafronyl oxalate salt) is a drug used in the management of peripheral and cerebral vascular disorders as a vasodilator, enhance cellular oxidative capacity, and may also be a 5-HT2 receptor antagonist.
3-(3,4-dihydroxyphenyl)-N-[3-({4-[3-(3,4-dihydroxyphenyl)propanamido]butyl}amino)propyl]propanamide
N-[4-[[5-(3-butyl-4-oxo-1,2-dihydroquinazolin-2-yl)-2-methoxyphenyl]methoxy]phenyl]acetamide
2-[2-[4-[2-Hydroxy-3-(2-methylphenoxy)propyl]-1-piperazinyl]ethyl]benzo[de]isoquinoline-1,3-dione
(4-Tert-butylphenyl)-[4-[4-nitro-3-(3-pyridinylmethylamino)phenyl]-1-piperazinyl]methanone
(1S,13S,14R,19R,22R)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1S,13R,14R,19R,22R)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1S,13R,14R,19R,22R)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,13R,14S,19S,22R)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,13R,14S,19S,22S)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,13S,14R,19R,22S)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,13S,14S,19R,22R)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1S,13S,14S,19S,22R)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,13S,14S,19R,22S)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,13S,14R,19S,22R)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1S,13S,14S,19R,22R)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1R,13R,14S,19R,22S)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1R,13S,14S,19R,22S)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1S,13R,14R,19S,22R)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1S,13R,14S,19R,22R)-13,22-dimethoxy-11,14,16-trimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
(3aR,4S,9bS)-4-(hydroxymethyl)-N-(2-methoxyphenyl)-8-(4-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
(3aS,4R,9bR)-4-(hydroxymethyl)-N-(2-methoxyphenyl)-8-(4-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
(2S,3S,3aR,9bR)-1-(cyclopropanecarbonyl)-2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-3-(hydroxymethyl)-7-[(Z)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
(2R,3R,3aS,9bS)-1-(cyclopropanecarbonyl)-2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-3-(hydroxymethyl)-7-[(Z)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
Usmarapride
Usmarapride (SUVN-D4010) is a potent, selective, orally active and brain penetrant 5-HT4 receptor partial agonist (EC50=44 nM). Usmarapride (SUVN-D4010) can be used for the research of cognitive deficits associated with Alzheimer's disease[1].